MA56391A - Agonistes du récepteur du peptide de type glucagon 1 - Google Patents
Agonistes du récepteur du peptide de type glucagon 1Info
- Publication number
- MA56391A MA56391A MA056391A MA56391A MA56391A MA 56391 A MA56391 A MA 56391A MA 056391 A MA056391 A MA 056391A MA 56391 A MA56391 A MA 56391A MA 56391 A MA56391 A MA 56391A
- Authority
- MA
- Morocco
- Prior art keywords
- glucagon
- peptide
- receptor agonists
- agonists
- receptor
- Prior art date
Links
- 239000003877 glucagon like peptide 1 receptor agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962868117P | 2019-06-28 | 2019-06-28 | |
PCT/US2020/038617 WO2020263695A1 (fr) | 2019-06-28 | 2020-06-19 | Agonistes du récepteur du peptide de type glucagon 1 |
Publications (2)
Publication Number | Publication Date |
---|---|
MA56391A true MA56391A (fr) | 2022-05-04 |
MA56391B1 MA56391B1 (fr) | 2023-11-30 |
Family
ID=80781601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA56391A MA56391B1 (fr) | 2019-06-28 | 2020-06-19 | Agonistes du récepteur du peptide de type glucagon 1 |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR119173A1 (fr) |
MA (1) | MA56391B1 (fr) |
-
2020
- 2020-06-17 AR ARP200101699A patent/AR119173A1/es unknown
- 2020-06-19 MA MA56391A patent/MA56391B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AR119173A1 (es) | 2021-12-01 |
MA56391B1 (fr) | 2023-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288479A (en) | Glucagon-like peptide 1 receptor agonists | |
DK3806855T3 (da) | GLP-1-receptoragonister og anvendelser deraf | |
DK3806955T3 (da) | GLP-1-receptoragonister og anvendelser deraf | |
ZA202006115B (en) | Phenylpyrrolidinone formyl peptide 2 receptor agonists | |
DK3810201T5 (da) | GIP/GLP1-agonist-sammensætninger | |
DK4122954T3 (da) | Novel GLP-1-analoger | |
SG11202001637PA (en) | Glucagon-like peptide 1 receptor agonists and uses thereof | |
MA50474A (fr) | Co-agonistes à action prolongée des récepteurs du glucagon et du glp-1 | |
EP3359191A4 (fr) | Conjugués anticorps-peptides ayant une activité agoniste au niveau des récepteurs au glucagon et au peptide-1 similaire au glucagon | |
IL291493A (en) | dap10/dap12 fusion polypeptides | |
MA56391A (fr) | Agonistes du récepteur du peptide de type glucagon 1 | |
GB201816639D0 (en) | GLP-1 Receptor Antagonist | |
GB201816650D0 (en) | GLP-1 Receptor antagonists | |
GB201910515D0 (en) | GLP-1 Receptor antagonists |